Found 78 matching trials
NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer. PHASE1 The purpose of this study is to evaluate the change in the expression of tr...
Show More Status
Active Not Recruiting
Location
Nebraska Cancer Specialists
Learn More & Join Trial
Imaging Characteristics of Different ⁶⁸Ga-PSMA Probes in Prostate Cancer NA This study aims to evaluate the imaging characteristics of \[⁶⁸Ga\]Ga-GS24-...
Show More Location
Multiple Locations
Learn More & Join Trial
Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT) PHASE2 In advanced metastatic castration resistant prostate cancer (mCRPC) progres...
Show More Location
UCLA / Jonsson Comprehensive Cancer Center
Learn More & Join Trial
68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy for Patients With Metastatic Castrate Resistant Prostate Cancer PHASE3 This phase III study provides access to 68Ga-PSMA-11 positron emission tomo...
Show More Location
Mayo Clinic in Rochester
Learn More & Join Trial
Study on the Diagnostic Value of Novel PET Molecular Imaging for Renal Cell Carcinoma NA This study is a diagnostic study. This project aims to explore the clinical...
Show More Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan PHASE4 The purpose of this research study is to see how well an imaging test, call...
Show More Location
Dana Farber Cancer Institute
Learn More & Join Trial
Novel Ga68-PSMA PET/CT-tracer to Differentiate Between Radiation Necrosis and Tumor Progression in Brain Metastases NA This study aims to evaluate the diagnostic potential of 68-Gallium PSMA-PET...
Show More Location
Netherlands Cancer Institute - Antoni van Leeuwenhoek
Learn More & Join Trial
Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer PHASE2 This phase II trial studies how to improve the usage of Lu 177 vipivotide t...
Show More Location
Mayo Clinic in Rochester
Learn More & Join Trial
Ga-68 Prostate Specific Membrane Antigen PET/CT in Gliomas NA As a part of molecular imaging, many PET tracers have been investigated in ...
Show More Location
All India Institute of Medical Sciences, Bhubaneswar
Learn More & Join Trial
Gallium Ga 68-labeled PSMA-11 PET/CT in Detecting Recurrent Prostate Cancer in Patients After Initial Therapy PHASE3 This clinical trial studies how well gallium Ga 68-labeled prostate-specifi...
Show More Location
UCLA / Jonsson Comprehensive Cancer Center
Learn More & Join Trial